Active Ingredient(s): Dasiglucagon Hydrochloride
FDA Approved: * March 22, 2021
Pharm Company: * ZEALAND PHARMA
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zegalogue Overview

Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.[1][2] The most common side effects include nausea, vomiting, headache, diarrhea, and injection site pain.[1] Dasiglucagon was approved for medical use in the United States in March 2021.[1][3][4][5] It was designated an orphan drug in August 2017.[6&a...

Read more Zegalogue Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dasiglucagon

Recent Zegalogue Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dasiglucagon Hydrochloride
  • Solution: 0.6mg/0.6ml (0.6mg/0.6ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Dasiglucagon Hydrochloride or a similar ingredient: (1 result)